![Ken Takeshita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Takeshita
No open positions remaining
Profile
Dr. Ken Takeshita, MD, is a Global Director-Research & Development at Daiichi Sankyo Co., Ltd. Dr. Takeshita was previously employed as a Senior VP & Global Head-Clinical Development by Kite Pharma, Inc.
Latest news about Ken Takeshita
Former positions of Ken Takeshita
| Companies | Position | End |
|---|---|---|
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 08/02/2021 |
| DAIICHI SANKYO CO., LTD. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Ken Takeshita
